APA

Perlstein D., Shlagman O., Kogan Y., Halevi-Tobias K., Yakobson A., Lazarev I. & Agur Z. (20200402). Personal response to immune checkpoint inhibitors of patients with advanced melanoma explained by a computational model of cellular immunity, tumor growth, and drug. : PloS one.

Chicago

Perlstein D, Shlagman O, Kogan Y, Halevi-Tobias K, Yakobson A, Lazarev I and Agur Z. 20200402. Personal response to immune checkpoint inhibitors of patients with advanced melanoma explained by a computational model of cellular immunity, tumor growth, and drug. : PloS one.

Harvard

Perlstein D., Shlagman O., Kogan Y., Halevi-Tobias K., Yakobson A., Lazarev I. and Agur Z. (20200402). Personal response to immune checkpoint inhibitors of patients with advanced melanoma explained by a computational model of cellular immunity, tumor growth, and drug. : PloS one.

MLA

Perlstein D, Shlagman O, Kogan Y, Halevi-Tobias K, Yakobson A, Lazarev I and Agur Z. Personal response to immune checkpoint inhibitors of patients with advanced melanoma explained by a computational model of cellular immunity, tumor growth, and drug. : PloS one. 20200402.